https://www.selleckchem.com/CDK.html
39, 95% CI 1.26-1.54; I2=36.5%, Q test =.16). Sensitivity analysis showed that the pooled HRs were constant after excluding one study at a time, and no significant publication biases were detected. The meta-analysis suggested that concomitant PPI use is significantly associated with low clinical benefit in ICI treatment, revealing a significantly reduced PFS and OS in advanced cancer patients receiving ICIs who are also exposed to PPI. The meta-analysis suggested that concomitant PPI use is significantly associated with low clinical benefit in ICI t